CareDx (CDNA)
CareDx on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as services-medical laboratories.
6.6M
Short interest
settlement 2026-09-30
4.6
Days to cover
-1.7 days vs prior
48.1%
Short share of volume
2026-10-09
155
Fails to deliver
settlement 2026-09-11
Tue 3 Nov
Next earnings
estimated date
-$9.4M
Insider flow, 90 days
0 buys, 9 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in CDNA is 6,587,070 shares, up 758,534 shares over the last month. Over the last 48 readings it ranged from 3,071,080 shares (15 November 2024) to 8,434,827 shares (15 June 2026). At the reported average volume of 1.4M shares a day that is 4.6 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/cdna" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 6,587,070 | +4.6% | 1,444,402 | 4.56 |
| 2026-09-15 | 6,297,191 | +8.0% | 1,001,222 | 6.29 |
| 2026-08-31 | 5,828,536 | +0.7% | 1,207,347 | 4.83 |
| 2026-08-14 | 5,789,862 | -5.6% | 1,150,605 | 5.03 |
| 2026-07-31 | 6,135,225 | -0.8% | 1,442,843 | 4.25 |
| 2026-07-15 | 6,187,364 | -25.8% | 797,456 | 7.76 |
| 2026-06-30 | 8,337,870 | -1.1% | 1,146,763 | 7.27 |
| 2026-06-15 | 8,434,827 | +32.4% | 784,954 | 10.75 |
| 2026-05-29 | 6,370,643 | -2.1% | 703,311 | 9.06 |
| 2026-05-15 | 6,507,297 | -5.6% | 574,540 | 11.33 |
| 2026-04-30 | 6,892,213 | +7.8% | 1,012,384 | 6.81 |
| 2026-04-15 | 6,395,360 | -0.3% | 560,724 | 11.41 |
| 2026-03-31 | 6,416,784 | -1.6% | 642,270 | 9.99 |
| 2026-03-13 | 6,519,157 | +3.9% | 571,339 | 11.41 |
| 2026-02-27 | 6,277,248 | +3.2% | 586,280 | 10.71 |
| 2026-02-13 | 6,083,254 | +5.8% | 721,614 | 8.43 |
| 2026-01-30 | 5,752,611 | +3.1% | 578,508 | 9.94 |
| 2026-01-15 | 5,577,014 | -5.3% | 957,054 | 5.83 |
| 2025-12-31 | 5,889,947 | -5.9% | 560,110 | 10.52 |
| 2025-12-15 | 6,260,094 | -4.8% | 928,284 | 6.74 |
| 2025-11-28 | 6,572,231 | -5.6% | 690,443 | 9.52 |
| 2025-11-14 | 6,961,045 | +6.0% | 1,503,147 | 4.63 |
| 2025-10-31 | 6,568,572 | +8.6% | 970,464 | 6.77 |
| 2025-10-15 | 6,046,844 | -3.2% | 1,067,925 | 5.66 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of CDNA volume is 48.1%, up 6.8 points over the last five sessions. Over the last 30 readings it ranged from 37.7% (7 October 2026) to 68.8% (1 October 2026). The latest reading is 5.6 points below the 30-session average of 53.7%, on 416K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 200K | 416K | 48.1% | 0 |
| 2026-10-08 | 336K | 543K | 61.8% | 320 |
| 2026-10-07 | 265K | 702K | 37.7% | 60 |
| 2026-10-06 | 595K | 1.2M | 48.1% | 1,081 |
| 2026-10-05 | 403K | 687K | 58.7% | 374 |
| 2026-10-02 | 312K | 755K | 41.4% | 86 |
| 2026-10-01 | 625K | 909K | 68.8% | 651 |
| 2026-09-30 | 341K | 662K | 51.6% | 290 |
| 2026-09-29 | 174K | 352K | 49.4% | 0 |
| 2026-09-28 | 274K | 446K | 61.4% | 7,280 |
| 2026-09-25 | 705K | 1.2M | 59.5% | 1,038 |
| 2026-09-24 | 690K | 1.2M | 57.4% | 3,950 |
| 2026-09-23 | 354K | 624K | 56.7% | 180 |
| 2026-09-22 | 360K | 612K | 58.9% | 4,075 |
| 2026-09-21 | 211K | 347K | 60.8% | 4 |
| 2026-09-18 | 196K | 289K | 67.6% | 0 |
| 2026-09-17 | 159K | 299K | 53.3% | 1 |
| 2026-09-16 | 221K | 339K | 65.1% | 0 |
| 2026-09-15 | 172K | 354K | 48.7% | 300 |
| 2026-09-14 | 155K | 344K | 44.9% | 4,752 |
| 2026-09-11 | 153K | 268K | 57.2% | 1,500 |
| 2026-09-10 | 299K | 549K | 54.4% | 310 |
| 2026-09-09 | 295K | 501K | 58.9% | 0 |
| 2026-09-08 | 238K | 444K | 53.7% | 25 |
| 2026-09-04 | 268K | 535K | 50.1% | 0 |
| 2026-09-03 | 147K | 261K | 56.5% | 0 |
| 2026-09-02 | 130K | 294K | 44.4% | 67 |
| 2026-09-01 | 151K | 324K | 46.7% | 401 |
| 2026-08-31 | 302K | 700K | 43.2% | 1,944 |
| 2026-08-28 | 256K | 542K | 47.2% | 4,816 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 11 September 2026, the fails-to-deliver balance in CDNA is 155 shares, up 95 shares over the last settlement date. Over the last 30 readings it ranged from 15 shares (19 December 2025) to 189,897 shares (17 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-11 | 155 | $50.02 | $8K |
| 2026-09-10 | 60 | $50.03 | $3K |
| 2026-09-09 | 122 | $50.31 | $6K |
| 2026-08-26 | 11,711 | $50.80 | $595K |
| 2026-08-24 | 271 | $48.61 | $13K |
| 2026-08-04 | 3,192 | $47.85 | $153K |
| 2026-07-31 | 348 | $38.10 | $13K |
| 2026-07-29 | 458 | $35.75 | $16K |
| 2026-07-23 | 2,060 | $37.78 | $78K |
| 2026-07-17 | 189,897 | $40.34 | $7.7M |
| 2026-07-16 | 285 | $29.75 | $8K |
| 2026-07-13 | 14,870 | $28.51 | $424K |
| 2026-06-30 | 80,638 | $29.28 | $2.4M |
| 2026-06-29 | 75,105 | $28.82 | $2.2M |
| 2026-06-22 | 561 | $26.18 | $15K |
| 2026-06-18 | 2,206 | $23.48 | $52K |
| 2026-06-17 | 76 | $23.25 | $2K |
| 2026-05-26 | 274 | $21.63 | $6K |
| 2026-05-08 | 24 | $21.44 | $515 |
| 2026-05-06 | 108 | $20.70 | $2K |
| 2026-05-04 | 318 | $21.50 | $7K |
| 2026-04-21 | 157 | $21.29 | $3K |
| 2026-04-20 | 769 | $21.42 | $16K |
| 2026-03-30 | 1,373 | $16.78 | $23K |
| 2026-02-27 | 117 | $18.82 | $2K |
| 2026-02-24 | 75 | $18.79 | $1K |
| 2026-01-26 | 64 | $20.42 | $1K |
| 2026-01-05 | 25,227 | $19.14 | $483K |
| 2025-12-19 | 15 | $19.19 | $288 |
| 2025-10-14 | 42 | $14.53 | $610 |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at CDNA reported 9 open-market sells worth $9.4M in the last 90 days and no open-market buys. Latest filing: Goldberg Michael (Director) on 2026-10-02.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Goldberg Michael | Director | Grant | 588 | $0.00 | $0 | 62K |
| 2026-10-01 | Meng Jessica | Chief Commercial Officer | Tax withholding | 3K | $66.23 | $173K | 159K |
| 2026-10-01 | Kennedy Keith | CFO & COO | Tax withholding | 3K | $66.23 | $200K | 209K |
| 2026-10-01 | Hanna John Walter JR | President and CEO | Tax withholding | 9K | $66.23 | $564K | 645K |
| 2026-10-01 | Novack Jeffrey Adam | Secretary and General Counsel | Tax withholding | 997 | $66.23 | $66K | 105K |
| 2026-09-12 | Meng Jessica | Chief Commercial Officer | Tax withholding | 7K | $52.37 | $350K | 162K |
| 2026-09-12 | Kennedy Keith | CFO & COO | Tax withholding | 8K | $52.37 | $430K | 212K |
| 2026-08-05 | Novack Jeffrey Adam | Secretary and General Counsel | Sell | 500 | $46.75 | $23K | 106K |
| 2026-08-05 | Novack Jeffrey Adam | Secretary and General Counsel | Sell | 2K | $46.15 | $101K | 107K |
| 2026-08-05 | Bickerstaff George | Director | Sell | 20K | $46.28 | $926K | 134K |
| 2026-08-04 | Goldberg Michael | Director | Sell | 45K | $47.06 | $2.1M | 62K |
| 2026-08-04 | COURNOYER CHRISTINE | Director | Sell | 16K | $46.94 | $751K | 43K |
| 2026-08-01 | Novack Jeffrey Adam | Secretary and General Counsel | Tax withholding | 3K | $47.85 | $137K | 109K |
| 2026-07-16 | Valantine Hannah | Director | Sell | 100 | $36.55 | $4K | 37K |
| 2026-07-16 | Valantine Hannah | Director | Sell | 29K | $36.14 | $1.0M | 37K |
| 2026-07-16 | Valantine Hannah | Director | Option exercise | 5K | $7.96 | $41K | 65K |
| 2026-07-16 | Valantine Hannah | Director | Option exercise | 16K | $14.19 | $228K | 60K |
| 2026-07-16 | Valantine Hannah | Director | Option exercise | 8K | $20.56 | $156K | 44K |
| 2026-07-16 | Hanna John Walter JR | President and CEO | Sell | 68K | $39.01 | $2.7M | 653K |
| 2026-07-16 | Hanna John Walter JR | President and CEO | Sell | 50K | $36.11 | $1.8M | 721K |
| 2026-07-16 | Hanna John Walter JR | President and CEO | Option exercise | 118K | $8.20 | $968K | 771K |
| 2026-07-02 | Goldberg Michael | Director | Grant | 2K | $0.00 | $0 | 106K |
| 2026-07-01 | Meng Jessica | Chief Commercial Officer | Tax withholding | 2K | $29.25 | $71K | 168K |
| 2026-07-01 | Novack Jeffrey Adam | Secretary and General Counsel | Tax withholding | 997 | $29.25 | $29K | 112K |
| 2026-07-01 | Kennedy Keith | CFO & COO | Tax withholding | 3K | $29.25 | $86K | 220K |
| 2026-07-01 | Hanna John Walter JR | President and CEO | Tax withholding | 9K | $29.25 | $249K | 653K |
| 2026-06-29 | Hanna John Walter JR | President and CEO | Sell | 40K | $29.24 | $1.2M | 662K |
| 2026-06-29 | Hanna John Walter JR | President and CEO | Option exercise | 40K | $8.20 | $327K | 702K |
| 2026-06-26 | Hanna John Walter JR | President and CEO | Sell | 100 | $29.00 | $3K | 662K |
| 2026-06-26 | Hanna John Walter JR | President and CEO | Option exercise | 100 | $8.20 | $820 | 662K |
| 2026-06-15 | Valantine Hannah | Director | Sell | 12K | $23.11 | $280K | 37K |
| 2026-06-15 | Hanna John Walter JR | President and CEO | Sell | 18K | $24.03 | $425K | 632K |
| 2026-06-15 | Hanna John Walter JR | President and CEO | Option exercise | 16K | $8.20 | $129K | 662K |
| 2026-06-12 | Goldberg Michael | Director | Grant | 10K | $0.00 | $0 | 196K |
| 2026-06-12 | Gunasekaran Suresh | Director | Grant | 10K | $0.00 | $0 | 37K |
| 2026-06-12 | Cohen Fred E | Director | Grant | 10K | $0.00 | $0 | 165K |
| 2026-06-12 | Riggsbee Richard Bryan | Director | Grant | 10K | $0.00 | $0 | 39K |
| 2026-06-12 | COURNOYER CHRISTINE | Director | Grant | 10K | $0.00 | $0 | 59K |
| 2026-06-12 | Valantine Hannah | Director | Grant | 10K | $0.00 | $0 | 49K |
| 2026-06-12 | Bickerstaff George | Director | Grant | 10K | $0.00 | $0 | 154K |
| 2026-06-11 | Hanna John Walter JR | President and CEO | Sell | 22K | $24.02 | $528K | 650K |
| 2026-06-11 | Hanna John Walter JR | President and CEO | Option exercise | 14K | $8.20 | $112K | 646K |
| 2026-06-06 | Novack Jeffrey Adam | Secretary and General Counsel | Tax withholding | 1K | $21.95 | $28K | 113K |
| 2026-06-04 | Hanna John Walter JR | President and CEO | Option exercise | 706 | $8.20 | $6K | 633K |
| 2026-06-04 | Hanna John Walter JR | President and CEO | Sell | 5K | $24.00 | $116K | 672K |
| 2026-05-15 | TORRES ARTHUR A | Director | Sell | 6K | $19.89 | $129K | 39K |
| 2026-05-14 | TORRES ARTHUR A | Director | Sell | 4K | $20.97 | $86K | 45K |
| 2026-05-05 | Novack Jeffrey Adam | Secretary and General Counsel | Sell | 3K | $20.68 | $56K | 114K |
| 2026-05-01 | Novack Jeffrey Adam | Secretary and General Counsel | Tax withholding | 3K | $21.50 | $62K | 117K |
| 2026-04-20 | Kennedy Keith | CFO & COO | Grant | 24K | $0.00 | $0 | 222K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON30 Form 144 notices on file for CDNA worth $23.1M at the prices reported; 16 in the last 90 days worth $18.3M. Latest: PETER MAAG filed on 2026-08-17 to sell 9,122 shares ($423K) from 2026-08-17.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-17 | PETER MAAGDirector | 9K | $423K | 0.018% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-14 | PETER MAAGDirector | 7K | $317K | 0.014% | 2026-08-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-13 | PETER MAAGDirector | 7K | $330K | 0.014% | 2026-08-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-12 | PETER MAAGDirector | 7K | $328K | 0.014% | 2026-08-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-11 | PETER MAAGDirector | 7K | $334K | 0.014% | 2026-08-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-10 | PETER MAAGDirector | 7K | $329K | 0.013% | 2026-08-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-10 | ARTHUR TORRESDirector | 4K | $200K | 0.008% | 2026-08-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-07 | PETER MAAGDirector | 27K | $1.3M | 0.053% | 2026-08-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-05 | PETER MAAGDirector | 47K | $2.2M | 0.091% | 2026-08-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-05 | JEFFREY NOVACKOfficer | 3K | $127K | 0.005% | 2026-08-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-05 | GEORGE W BICKERSTAFFDirector | 20K | $926K | 0.039% | 2026-08-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-04 | MICHAEL D. GOLDBERG FAM TRUSTDirector | 45K | $2.1M | 0.086% | 2026-08-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-04 | PETER MAAGDirector | 76K | $3.6M | 0.146% | 2026-08-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-04 | CHRISTINE COURNOYERDirector | 32K | $1.5M | 0.062% | 2026-08-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-16 | JOHN WALTER HANNADirector, Officer | 118K | $3.5M | 0.228% | 2026-07-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-16 | HANNAH VALANTINEDirector | 29K | $856K | 0.056% | 2026-07-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-29 | JOHN HANNADirector, Officer | 40K | $1.1M | 0.076% | 2026-06-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-15 | HANNAH VALANTINEDirector | 12K | $278K | 0.023% | 2026-06-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-11 | JOHN HANNADirector, Officer | 40K | $943K | 0.078% | 2026-06-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-04 | JOHN WALTER HANNADirector, Officer | 5K | $108K | 0.009% | 2026-06-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-15 | ARTHUR TORRESDirector | 6K | $129K | 0.013% | 2026-05-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-14 | ARTHUR TORRESDirector | 4K | $86K | 0.008% | 2026-05-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-05 | JEFFREY NOVACKOfficer | 3K | $56K | 0.005% | 2026-05-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-16 | JOHN HANNADirector, Officer | 10K | $181K | 0.020% | 2026-04-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-03 | JEFFREY NOVACKOfficer | 4K | $91K | 0.009% | 2026-02-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-15 | JOHN HANNADirector, Officer | 30K | $602K | 0.058% | 2026-01-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-04 | JEFFREY NOVACKOfficer | 7K | $137K | 0.014% | 2025-12-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-07 | Jeffrey Adam NovackOfficer | 3K | $40K | 0.005% | 2025-11-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-05 | ABHISHEK JAINOfficer | 53K | $842K | 0.104% | 2025-11-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-31 | ABHISHEK JAINOfficer | 10K | $148K | 0.019% | 2025-10-31 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON1 holder reports 5% or more of CDNA in its latest filing, on Schedule 13G (passive). The holder is BlackRock, Inc. at 9.0% of the class (4,664,092 shares), filed 2026-07-27 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 1 | Baron Capital Group, Inc.corporation, parent holding company | 1.9M | 3.8% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Ronald Baronindividual, parent holding company | 1.9M | 3.8% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | BAMCO INC /NY/corporation, investment adviser | 1.7M | 3.2% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 1 | Baron Capital Management, Inc.corporation, investment adviser | 274K | 0.5% | 2026-06-30 |
| 2026-08-07 | 13G/Ano. 2 | Neil Gagnonindividual | 2.3M | 4.4% | 2026-07-31 |
| 2026-08-07 | 13G/Ano. 2 | Gagnon Securities LLCbroker-dealer, investment adviser | 1.6M | 3.2% | 2026-07-31 |
| 2026-08-07 | 13G/Ano. 2 | Gagnon Advisors, LLCinvestment adviser | 409K | 0.8% | 2026-07-31 |
| 2026-08-07 | 13G | STATE STREET CORPORATIONparent holding company | 2.5M | 4.8% | 2026-06-30 |
| 2026-07-27 | 13G/Ano. 8 | BlackRock, Inc.parent holding company | 4.7M | 9.0% | 2026-06-30 |
| 2026-03-26 | 13G/Ano. 9 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding CDNA at their latest 13F. JSON7 of the 30 tracked managers held CDNA at their latest 13F, $147.1M in total at quarter-end prices. ARK Investment Management is the largest at $55.7M (0.4% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| ARK Investment Management | 2026-06-30 | 2.0M | $55.7M | 0.36% | -274K |
| Renaissance Technologies | 2026-06-30 | 1.2M | $35.4M | 0.05% | +59K |
| D. E. Shaw & Co. | 2026-06-30 | 1.1M | $32.4M | 0.02% | +263K |
| Two Sigma Investments | 2026-06-30 | 402K | $11.5M | 0.01% | +170K |
| AQR Capital Management | 2026-06-30 | 244K | $7.0M | 0.00% | -105K |
| Citadel Advisors | 2026-06-30 | 107K | $3.0M | 0.00% | +23K |
| Millennium Management | 2026-06-30 | 74K | $2.1M | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) CareDx reported revenue of $131.9M, up 52.2% from the same quarter a year earlier, and net income of $110.6M (2.07 diluted EPS). In FY 2025 it generated $42.0M of operating cash flow and spent $87.8M on buybacks.
- Cash
- $373.6M
- Equity
- $425.6M
- Total assets
- $533.0M
- Shares outstanding
- 51,734,223
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $131.9M | $110.6M | 83.8% | 2.07 |
| Q1 FY 2026 | 2026-03-31 | $117.7M | $2.8M | 2.4% | 0.05 |
| Q4 FY 2025derived | 2025-12-31 | $108.4M | -$4.1M | -3.8% | n/a |
| Q3 FY 2025 | 2025-09-30 | $100.1M | $1.7M | 1.7% | 0.03 |
| Q2 FY 2025 | 2025-06-30 | $86.7M | -$8.6M | -9.9% | -0.16 |
| Q1 FY 2025 | 2025-03-31 | $84.7M | -$10.4M | -12.2% | -0.19 |
| Q4 FY 2024derived | 2024-12-31 | $86.6M | $87.7M | 101.3% | n/a |
| Q3 FY 2024 | 2024-09-30 | $82.9M | -$10.6M | -12.8% | -0.20 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $379.8M | -$21.4M | $42.0M | n/a | $87.8M | n/a |
| FY 2024 | 2024-12-31 | $333.8M | $52.5M | $38.0M | n/a | $522K | n/a |
| FY 2023 | 2023-12-31 | $280.3M | -$190.3M | -$18.4M | n/a | $27.5M | n/a |
| FY 2022 | 2022-12-31 | $321.8M | -$76.6M | -$25.2M | n/a | $642K | n/a |
| FY 2021 | 2021-12-31 | $296.4M | -$30.7M | -$19.3M | n/a | $0 | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-27 from the cover page.
What this page is
CareDx in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows CareDx (CDNA), SEC CIK 1217234, listed on Nasdaq, classified by the SEC as services-medical laboratories. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-11.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-17.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-02.JSON and CSV
- Company record
- EDGAR filing index for CIK 1217234Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-medical laboratories
Other company pages
Datasets
Frequently Asked Questions
How much of CDNA is sold short?
What is CDNA's daily short volume?
Does CDNA have fails to deliver?
Are CDNA insiders buying or selling?
Have CDNA insiders filed to sell?
Who owns 5% or more of CDNA?
What did CDNA report last quarter?
Which tracked 13F managers own CDNA?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.